Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit |
Sponsor |
Date |
|---|---|---|---|---|---|---|---|
| WAESO: Exercised Sheep Loading and Motion Analysis | Grant | $460.50 | Research Training | John Szivek | Orthopaedic Surgery | Arizona State University | 07/2020 |
| Compassionomics | Grant | $700.00 | Research | Susan McCartan | COM Phoenix Academic Affairs | Arnold P. Gold Foundation | 03/2020 |
| Total Shoulder Arthroplasty Multi-Center Registry | Contract | $603,643.00 | Clinical Trial | Joshua Hustedt | COM Phx Orthopedics | Arthrex, Incorporated | 06/2020 |
| A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors | Contract | $513,891.00 | Clinical Trial | Montaser Shaheen | Cancer Center Division | Ascentage Pharma | 01/2020 |
| Developing and Piloting a Scalable, Online, Interprofessional Health Equity and Social Justice Course | Contract | $6,000.00 | Research | Elizabeth Hall-Lipsy | Pharmacy Practice and Science | Association for Prevention Teaching and Research | 02/2021 |
| UT2 Autism Intervention Research Network for Physical Health (AIR-P) | Cooperative Agreement | $20,000.00 | Other Sponsored Activity | Wendy Parent-Johnson | Family and Community Medicine | Association of University Centers on Disability | 03/2021 |
| A Phase 1 Study of Safety, Pharmacokinetics and Preliminary Activity of TAS1440, as a Single Agent and in Combination with All-Trans Retinoic Acid (ATRA) in Subjects with Relapsed or Refractory (r/r) | Contract | $128,345.24 | Clinical Trial | Sharad Khurana | Cancer Center Division | Astex Pharmaceuticals Incorporated | 06/2021 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with... | Contract | $1,278,228.50 | Clinical Trial | Charles Hsu | Radiation Oncology | Astrazeneca | 08/2020 |
| A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab | Contract | $208,612.70 | Clinical Trial | Gregory Woodhead | Cancer Center Division | Astrazeneca | 06/2020 |
| A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies | Contract | $468,451.00 | Clinical Trial | Alejandro Recio Boiles | Cancer Center Division | Atreca, Inc. | 10/2020 |
| Mycardia Implant Viability and Biodistribution in RNU Rats | Contract | $18,977.00 | Research - Industry (62.5% MTDC) | Joshua Strom | Cellular & Molecular Medicine | Avery Therapeutics | 09/2020 |
| A Prospective Multicenter Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of the RECELL System Combined with Meshed Autograft for Reduction of Donor Skin Harvesting | Contract | $229,008.88 | Clinical Trial | Lourdes Castanon | Surgery | Avita Medical Americas, LLC | 01/2021 |
| Arizona Alzheimer's Disease Core Center (ADCC) - Developing Inhibitors of TDP-43/Tau Interaction for AD Therapeutics | Grant | $46,050.00 | Research | May Khanna | Pharmacology | Banner Health System | 02/2021 |
| Disease Morphology Image Study Protocol: A Retrospective, Multicenter, Data collection study for information about the disease morphology and stent restenosis patterns in the Iliac and SFA arteries, w | Contract | $17,187.52 | Clinical Trial | Kresimira Milas | Surgery | Bard Peripheral Vascular, Inc. | 05/2020 |
| Invasive Cardiopulmonary Exercise Testing to Phenotype Post Pulmonary Embolism Dyspnea | Contract | $99,577.00 | Clinical Trial | Michael Insel | Medicine | Bayer Healthcare Pharmaceuticals Incorporated | 11/2020 |
| An Open-Label Study of Regorafenib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Hepatocellular Carcinoma (HCC) after PD-1/PD-L1 Immune Checkpoint Inhibitors | Contract | $345,140.00 | Clinical Trial | Rachna Shroff | Cancer Center Division | Bayer Healthcare Pharmaceuticals Incorporated | 04/2021 |
| A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Finerenone on Morbidity and Mortality in Participants with Heart Failure (NYHA | Contract | $883,627.00 | Clinical Trial | Preethi William | Sarver Heart Center | Bayer Healthcare Pharmaceuticals Incorporated | 05/2021 |
| An Open-label, Phase 1, First-in-human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Maximum Tolerated or Administered Dose, Pharmacokinetics, Pharmacodynamics and Tumor.. | Contract | $2,247,249.52 | Clinical Trial | Ricklie Julian | Cancer Center Division | Bayer Pharmaceutical | 04/2021 |
| Space-based Paper Microfluidic Vertical Flow Assay for Rapid Multiplex Diagnostics (VFD) in COVID-19 Pandemic Response and Recovery | Cooperative Agreement | $149,958.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | Baylor College of Medicine | 07/2020 |
| Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer | Cooperative Agreement | $64,679.91 | Research | Denise Roe | Cancer Center Division | Beckman Research Institute of The City of Hope | 03/2020 |
| Immune Tolerance Network | Cooperative Agreement | $585,150.00 | Clinical Trial | Tara Carr | Asthma/Airway Disease Rsch Ctr | Benaroya Research Institute at Virginia Mason | 05/2021 |
| Establishing an Animal Model to Evaluate Nox4 Inhibitors for Skin Fibrosis | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| Evaluating Efficacy of NADPH Oxidase-4 Inhibitors for Pro-Fibrotic Effects in Skin Fibrosis | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| Evaluation of Novel Nox4 Inhibitor on Alveolar Epithelial Cell Proliferation | Grant | $450.00 | Research Training | Louise Hecker | Medicine | Beta Beta Beta National Biological Honor Society | 05/2020 |
| A Multicenter, Double-Blind, Multidose, Placebo-Controlled, Randomized, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 for Patients with Brain Contusion | Contract | $96,267.00 | Clinical Trial | Bellal Joseph | Surgery | Biogen Incorporated | 03/2020 |